Product Description
| Cat Number | T2513 |
|---|---|
| Category | Biochemical |
| Pack Size | 1EA |
| Description | VX-702 is a highly specific p38α MAPK inhibitor, 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA). |
| Molecular Weight | 404.32 |
| Purity | 0.9896 |
| Formula | C19H12F4N4O2 |
| Smiles | NC(=O)N(c1ccc(C(N)=O)c(n1)-c1ccc(F)cc1F)c1c(F)cccc1F |
| Storage | -20 ℃ |
| View Document | |
| Note | This product is for Research Use Only |
Share Item: